Detail of the clinical trial

Title of the trial Treatment optimization of newly diagnosed Ph/BCR-ABL positive patients with chronic myeloid leukemia (CML) in chronic phase with nilotinib vs. nilotinib plus interferon alpha induction and nilotinib or interferon alpha maintenance therapy.
EudraCT number 2010-024262-22
Protocol number CML-V
Sponsor Friedrich-Schiller-Universität Jena,Erlanger Allee 101,Jena,07747
Indications Hematology
Diagnosis chronic myeloid leukemia
Population in clinical trial Adults (18-65 years)
Elderly ( > 65 years)
Male
Female
Patients
Year of receiving the request to Institute (SÚKL) 2013
Date of approval by Institute (SÚKL) 6.3.2014
Date of approval by EC 25.9.2013
Date of initiation CT in ČR 3.7.2014
Date of ending CT in ČR
Notice
Sites Fakultní nemocnice Brno,Interní hematoonkologická klinika,Jihlavská 20,Brno,62500

‹‹ Back to list